NO853255L - Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin. - Google Patents

Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin.

Info

Publication number
NO853255L
NO853255L NO853255A NO853255A NO853255L NO 853255 L NO853255 L NO 853255L NO 853255 A NO853255 A NO 853255A NO 853255 A NO853255 A NO 853255A NO 853255 L NO853255 L NO 853255L
Authority
NO
Norway
Prior art keywords
methyl
benzazepine
tetrahydro
approx
trichlorobenzene
Prior art date
Application number
NO853255A
Other languages
English (en)
Norwegian (no)
Inventor
Stanley John Borowski
Thomas Anthony Post
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO853255L publication Critical patent/NO853255L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO853255A 1984-09-05 1985-08-19 Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin. NO853255L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/647,552 US4541954A (en) 1984-09-05 1984-09-05 Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Publications (1)

Publication Number Publication Date
NO853255L true NO853255L (no) 1986-03-06

Family

ID=24597406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853255A NO853255L (no) 1984-09-05 1985-08-19 Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin.

Country Status (19)

Country Link
US (1) US4541954A (en:Method)
EP (1) EP0174118A3 (en:Method)
JP (1) JPS6168469A (en:Method)
KR (1) KR860002470A (en:Method)
AU (1) AU581918B2 (en:Method)
CA (1) CA1244017A (en:Method)
DK (1) DK379985A (en:Method)
EG (1) EG17149A (en:Method)
ES (1) ES8609266A1 (en:Method)
FI (1) FI853255L (en:Method)
GR (1) GR852041B (en:Method)
HU (1) HU194181B (en:Method)
IL (1) IL76100A0 (en:Method)
NO (1) NO853255L (en:Method)
NZ (1) NZ213141A (en:Method)
PH (1) PH20796A (en:Method)
PT (1) PT81018B (en:Method)
ZA (1) ZA856268B (en:Method)
ZW (1) ZW13385A1 (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
CA2100678A1 (en) * 1991-12-06 1993-06-07 Hiroshi Kagawa Film type battery and layer-built film type battery
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
JP4782003B2 (ja) 2003-06-17 2011-09-28 アリーナ ファーマシューティカルズ, インコーポレイテッド 5ht2cレセプター関連疾患の処置に有用なベンズアゼピン誘導体
EP2332921B1 (en) 2003-06-17 2016-03-02 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
NZ555981A (en) 2004-12-21 2011-01-28 Arena Pharm Inc Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
EP2111859A1 (en) 2004-12-23 2009-10-28 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
JP5404414B2 (ja) * 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
CN102015591B (zh) * 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
US20130315994A1 (en) 2010-09-01 2013-11-28 Zezhi Jesse Shao Modified-release dosage forms of 5-ht2c agonists useful for weight management
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストの非吸湿性塩
CA2808909A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
SG10201506896RA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4251660A (en) * 1978-08-10 1981-02-17 Smithkline Corporation Method for preparing tetrahydroisoquinolines
US4200754A (en) * 1979-02-02 1980-04-29 Smithkline Corporation Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
EP0161350A1 (en) * 1981-11-27 1985-11-21 Smithkline Beckman Corporation Process for preparing benzazepines
ZA827887B (en) * 1981-11-27 1983-11-30 Smithkline Beckman Corp Pharmaceutical compositions and method of producing alpha2 antagonism
IE53962B1 (en) * 1981-11-27 1989-04-26 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists

Also Published As

Publication number Publication date
EP0174118A2 (en) 1986-03-12
JPS6168469A (ja) 1986-04-08
PH20796A (en) 1987-04-14
IL76100A0 (en) 1985-12-31
HU194181B (en) 1988-01-28
PT81018B (en) 1987-06-24
GR852041B (en:Method) 1985-12-19
ZW13385A1 (en) 1985-11-20
US4541954A (en) 1985-09-17
PT81018A (en) 1985-09-01
AU581918B2 (en) 1989-03-09
DK379985D0 (da) 1985-08-21
ZA856268B (en) 1986-07-30
AU4648185A (en) 1986-03-13
NZ213141A (en) 1988-07-28
DK379985A (da) 1986-03-06
ES8609266A1 (es) 1986-09-01
EG17149A (en) 1989-06-30
EP0174118A3 (en) 1986-12-30
KR860002470A (ko) 1986-04-26
FI853255A7 (fi) 1986-03-06
CA1244017A (en) 1988-11-01
HUT38617A (en) 1986-06-30
FI853255L (fi) 1986-03-06
FI853255A0 (fi) 1985-08-23
ES546285A0 (es) 1986-09-01

Similar Documents

Publication Publication Date Title
NO853255L (no) Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin.
US4172074A (en) Preparation of an antidepressant
US3978085A (en) Process for benz[f]-2,5-oxazocines
US6559319B2 (en) Synthesis of compounds useful in the manufacture of ketorolac
WO1998005657A1 (en) 2,3-dihydro-1,4-benzothiazepines, their preparation and their use as intermediates
JP2543983B2 (ja) 4―ジ置換フェニル―1―テトラロン類の製造方法
US3464977A (en) 5-(amino-loweralkyl)-4,5-dihydrothieno-(2,3-b)benzothiazepin-4-ones
US5274131A (en) 2-chloropropionaldehyde trimer and production process thereof
US3428677A (en) Chemical compounds and methods of preparing same
EP0090203B1 (en) Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
CN100558727C (zh) 喹唑啉生物碱类产品的制备方法
KR880002290B1 (ko) N-[2-(2-아미노-2-페닐에틸)페닐]-2.2-디메틸프로판아미드의 제조방법
JPH05178833A (ja) N−シアノアセトアミジン誘導体の製造方法
NO131345B (en:Method)
US4656289A (en) 1,3-dibenzyl-4-halohexahydro-1H-thieno[3,4-d]imidazol-2(3H)-one intermediates
KR100486320B1 (ko) 5,11-디히드로-6에이치-디벤즈[비,이]아제핀-6-온의제조방법
US3329677A (en) N-benzhydryloxyphthalimides and pryidinealdehyde o-benzhydryloximes
KR100486316B1 (ko) 5,11-디히드로-6에이치-디벤즈[비,이]아제핀-6-온의새로운 제조방법
JPS6054948B2 (ja) α,β↓−不飽和環状脂肪族ケトキシムから芳香族アミンを製造する方法
EP0370366A2 (en) Resolution process for benzazepine intermediates
US1930753A (en) Chlorination of cresidine
US4159381A (en) 4-(P-Fluorobenzoyl)-1-[3-(p-fluorobenzoyl)propyl]piperidine
US4048169A (en) 1,3-Bis-(β-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine-naphthalene-1,5-disulphonate
NO140717B (no) Fremgangsmaate til fremstilling av 5-cykloalkyl-6-halogen-indan-1-karboksylsyre og salter derav
JPH0583537B2 (en:Method)